Coronavirus information from UCLA and UCLA Health.

Latest News

Turnstone Biologics Acquires Novel Cell Therapy Platform

Turnstone Biologics Acquires Novel Cell Therapy Platform

urnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, today announced that it has acquired California-based Myst Therapeutics, a privately held biotechnology company...

Assay Development Scientist

Assay Development Scientist

Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe...

ImmunoVec Lab Manager Position

ImmunoVec Lab Manager Position

ImmunoVec was created to bring technologies that grew out of the Gene Therapy Program at UCLA to the clinic. Building upon discoveries that have produced potent treatments for genetic disorders, we plan to utilize our fusion of leading scientists and successful...

Magnify at CNSI Laboratory Manager Position

Magnify at CNSI Laboratory Manager Position

The Next Generation Incubator Centrally located at UCLA’s Court of Sciences, Magnify strives to enhance the vibrant culture of entrepreneurship at UCLA and the broader Los Angeles region. Featuring flexible co-working laboratory and office spaces, Magnify was built...

Appia Bio – Research Associate Position

Appia Bio – Research Associate Position

Appia Bio is a new startup with the mission to bring innovative cell therapies to more patients. Our novel platform can create a broad array of allogeneic NKT and T cell types, and can be further engineered to address challenges specific to tumor microenvironments....